Crossmark

Methylprednisolone treatment enhances early recovery following surgical decompression for degenerative cervical myelopathy without compromise to the systemic immune system

Crossref DOI link: https://doi.org/10.1186/s12974-018-1257-7

Published Online: 2018-08-06

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Vidal, Pia M.

Ulndreaj, Antigona

Badner, Anna

Hong, James

Fehlings, Michael G. https://orcid.org/0000-0002-5722-6364
Funding

Funding for this research was provided by:

Cervical Spine Research Society

Krembil Research Institute
License Information

Text and Data Mining valid from 2018-08-06
More Information

Article History

Received: 17 April 2018

Accepted: 17 July 2018

First Online: 6 August 2018

Ethics approval

: The Animal Use Committee at the University Health Network (UHN; Toronto, Canada) approved the study protocol, and all experiments were carried out in accordance with the committee recommendations.

: Not applicable

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below